{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:25:43Z","timestamp":1794435943913,"version":"4.9.1"},"reference-count":202,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["KJZD- M202300103"],"award-info":[{"award-number":["KJZD- M202300103"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2025NSCQ-LZX0011"],"award-info":[{"award-number":["CSTB2025NSCQ-LZX0011"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omtn.2026.102917","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:04:07Z","timestamp":1774465447000},"page":"102917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unlocking the potential of mRNA nanomedicines for comprehensive fibrosis therapy"],"prefix":"10.1016","volume":"37","author":[{"given":"Yue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1195-1031","authenticated-orcid":false,"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102917_bib1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","article-title":"Targeting fibrosis: Mechanisms and clinical trials","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omtn.2026.102917_bib2","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3390\/biomedicines10092178","article-title":"Novel therapies for the treatment of cardiac fibrosis following myocardial infarction","volume":"10","author":"Raziyeva","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtn.2026.102917_bib3","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtn.2026.102917_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2026.102917_bib5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2026.102917_bib6","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2026.102917_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s12967-025-06514-2","article-title":"Pulmonary fibrosis: from mechanisms to therapies","volume":"23","author":"Jiang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.omtn.2026.102917_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduction Targeted Ther."},{"key":"10.1016\/j.omtn.2026.102917_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202410416","article-title":"Targeting fibrosis: From molecular mechanisms to advanced therapies","volume":"12","author":"Di","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib10","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","article-title":"Pulmonary fibrosis: from pathogenesis to clinical decision-making","volume":"29","author":"Koudstaal","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtn.2026.102917_bib11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3390\/cells10051097","article-title":"Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?","volume":"10","author":"Khanam","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2026.102917_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2023.09.001","article-title":"Mechanisms of kidney fibrosis and routes towards therapy","volume":"35","author":"Yamashita","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.omtn.2026.102917_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jcph.1553","article-title":"Pharmacokinetics of patisiran, the first approved RNA interference therapy in patients with hereditary transthyretin-mediated amyloidosis","volume":"60","author":"Zhang","year":"2020","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.omtn.2026.102917_bib14","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102917_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2026.102917_bib16","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.vaccine.2019.04.074","article-title":"mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials","volume":"37","author":"Feldman","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2026.102917_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123199","article-title":"Nanomedicine in cardiology: Precision drug delivery for enhanced patient outcomes","volume":"358","author":"Peng","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib18","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41591-022-02061-1","article-title":"The landscape of mRNA nanomedicine","volume":"28","author":"Huang","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.102917_bib19","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.1912012117","article-title":"Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier","volume":"117","author":"Marcos-Contreras","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102917_bib20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","article-title":"Targeting cancer with mRNA\u2013lipid nanoparticles: Key considerations and future prospects","volume":"20","author":"Kon","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omtn.2026.102917_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123155","article-title":"Bivalent mRNA vaccines against three SARS-CoV-2 variants mediated by new ionizable lipid nanoparticles","volume":"642","author":"Wang","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2026.102917_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.omtn.2026.102917_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116130","article-title":"The involvement of the Wnt\/\u03b2-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxin","volume":"223","author":"Somanader","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.omtn.2026.102917_bib198","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/cvr\/cvx004","article-title":"JAK-STAT signalling and the atrial fibrillation promoting fibrotic substrate","volume":"113","author":"Chen","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.omtn.2026.102917_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116413","article-title":"Targeting MAPK-ERK\/JNK pathway: A potential intervention mechanism of myocardial fibrosis in heart failure","volume":"173","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtn.2026.102917_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.omtn.2022.04.006","article-title":"CircERBB2IP promotes post-infarction revascularization via the miR-145a-5p\/Smad5 axis","volume":"28","author":"Long","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102917_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.semcancer.2022.09.004","article-title":"TGF-\u03b2 in developmental and fibrogenic EMTs","volume":"86","author":"Lee","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.omtn.2026.102917_bib24","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtn.2026.102917_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101063","article-title":"Wnt signaling pathway in aging-related tissue fibrosis and therapies","volume":"60","author":"Hu","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.omtn.2026.102917_bib28","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.12659\/MSM.906038","article-title":"Platelet Derived Growth Factor Alpha (PDGFR\u03b1) Induces the Activation of Cardiac Fibroblasts by Activating c-Kit","volume":"23","author":"Wang","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.omtn.2026.102917_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.745308","article-title":"PDGF promotes dermal fibroblast activation via a novel mechanism mediated by signaling through MCHR1","volume":"12","author":"Takamura","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.102917_bib30","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1021\/acsnano.3c06107","article-title":"Antioxidative Hyaluronic Acid-Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy","volume":"18","author":"Shinn","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtn.2026.102917_bib31","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1097\/HEP.0000000000000182","article-title":"Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines","volume":"78","author":"Gong","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2026.102917_bib32","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.3390\/ijms26136202","article-title":"Therapeutic prospects of \u03b1v integrins inhibition in fibrotic lung diseases and carcinogenesis","volume":"26","author":"Golovina","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12964-024-01623-9","article-title":"Targeting wnt\/\u03b2-catenin signaling and its interplay with TGF-\u03b2 and notch signaling pathways for the treatment of chronic wounds","volume":"22","author":"Gumede","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.omtn.2026.102917_bib34","doi-asserted-by":"crossref","first-page":"90579","DOI":"10.18632\/oncotarget.21234","article-title":"Interactions between TGF-\u03b21, canonical WNT\/\u03b2-catenin pathway and PPAR \u03b3 in radiation-induced fibrosis","volume":"8","author":"Vall\u00e9e","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.omtn.2026.102917_bib35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: Mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2026.102917_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112115","article-title":"Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis","volume":"143","author":"Yan","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtn.2026.102917_bib37","doi-asserted-by":"crossref","first-page":"C1046","DOI":"10.1152\/ajpcell.00302.2023","article-title":"Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis","volume":"325","author":"Perrot","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.omtn.2026.102917_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41423-020-00560-0","article-title":"Neutrophils in liver diseases: pathogenesis and therapeutic targets","volume":"18","author":"Liu","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.omtn.2026.102917_bib39","article-title":"Pulmonary fibrosis through the prism of NLRP3 inflammasome: Mechanistic pathways and prospective therapeutic innovations","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.102917_bib40","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","article-title":"Nerandomilast in patients with idiopathic pulmonary fibrosis","volume":"392","author":"Richeldi","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102917_bib41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/life14020229","article-title":"Targeting progression in pulmonary fibrosis: An overview of underlying mechanisms, molecular biomarkers, and therapeutic intervention","volume":"14","author":"D\u2019Agnano","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.omtn.2026.102917_bib42","article-title":"Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF)","volume":"10","author":"Richeldi","year":"2023","journal-title":"BMJ Open Respir. Res."},{"key":"10.1016\/j.omtn.2026.102917_bib43","first-page":"2003","article-title":"Oxidative stress, mitochondrial damage and neurodegenerative diseases","volume":"8","author":"Guo","year":"2013","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.omtn.2026.102917_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12929-022-00850-x","article-title":"The novel role of ER protein TXNDC5 in the pathogenesis of organ fibrosis: mechanistic insights and therapeutic implications","volume":"29","author":"Hung","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97970-5","article-title":"Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement","volume":"11","author":"Korhonen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.102917_bib46","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00733-2020","article-title":"Anti-HSP47 siRNA lipid nanoparticle ND-L02-s0201 reverses interstitial pulmonary fibrosis in preclinical rat models","volume":"7","author":"Liu","year":"2021","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.omtn.2026.102917_bib47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"65","author":"Frangogiannis","year":"2019","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.omtn.2026.102917_bib48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-021-00646-w","article-title":"Transforming growth factor-\u03b2 in myocardial disease","volume":"19","author":"Frangogiannis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.omtn.2026.102917_bib49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","article-title":"Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation","volume":"127","author":"Gibb","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtn.2026.102917_bib50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","article-title":"The fibrogenic niche in kidney fibrosis: components and mechanisms","volume":"18","author":"Li","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.omtn.2026.102917_bib51","doi-asserted-by":"crossref","first-page":"C781","DOI":"10.1152\/ajpcell.00353.2020","article-title":"Tenascin-C in cardiac disease: A sophisticated controller of inflammation, repair, and fibrosis","volume":"319","author":"Imanaka-Yoshida","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.omtn.2026.102917_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4087632","article-title":"Inflammatory cardiomyopathy: A current view on the pathophysiology, diagnosis, and treatment","volume":"2016","author":"Krejci","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.omtn.2026.102917_bib53","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s12964-024-01842-0","article-title":"The role of nonmyocardial cells in the development of diabetic cardiomyopathy and the protective effects of FGF21: A current understanding","volume":"22","author":"Zhang","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.omtn.2026.102917_bib54","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/s41419-022-05403-6","article-title":"MYBPC3 deficiency in cardiac fibroblasts drives their activation and contributes to fibrosis","volume":"13","author":"Zou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtn.2026.102917_bib55","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1038\/s41467-022-30630-y","article-title":"Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-\u03b2-IGFBP7 axis","volume":"13","author":"Ko","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102917_bib56","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2375033","article-title":"Screening of active components in Astragalus mongholicus Bunge and Panax notoginseng formula for anti-fibrosis in CKD: nobiletin inhibits Lgals1\/PI3K\/AKT signaling to improve renal fibrosis","volume":"46","author":"Yang","year":"2024","journal-title":"Ren. Fail."},{"key":"10.1016\/j.omtn.2026.102917_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105342","article-title":"Design, synthesis and bioactivity evaluation of thiazolidinedione derivatives as partial agonists targeting PPAR\u03b3","volume":"116","author":"Sun","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.omtn.2026.102917_bib58","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1021\/acs.jmedchem.8b01573","article-title":"Structural basis of altered potency and efficacy displayed by a major in vivo metabolite of the antidiabetic PPAR\u03b3 drug pioglitazone","volume":"62","author":"Mosure","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.omtn.2026.102917_bib59","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","article-title":"Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis","volume":"17","author":"Moss","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.omtn.2026.102917_bib60","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s40265-023-01950-0","article-title":"Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis","volume":"83","author":"Bonella","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.omtn.2026.102917_bib61","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.3390\/ijms24044004","article-title":"Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation","volume":"24","author":"Antar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib62","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.3390\/ijms25147873","article-title":"Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells","volume":"25","author":"Akk\u0131z","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111572","article-title":"Hepatic stellate cell senescence in liver fibrosis: Characteristics, mechanisms and perspectives","volume":"199","author":"Zhang","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.omtn.2026.102917_bib64","first-page":"101","article-title":"Ofev (nintedanib): First tyrosine kinase inhibitor approved for the treatment of patients with idiopathic pulmonary fibrosis","volume":"8","author":"Fala","year":"2015","journal-title":"Am. Health Drug Benefits"},{"key":"10.1016\/j.omtn.2026.102917_bib65","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1183\/09059180.00011514","article-title":"Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis","volume":"24","author":"Cottin","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.omtn.2026.102917_bib66","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/TCRM.S81141","article-title":"Role of pirfenidone in the management of pulmonary fibrosis","volume":"13","author":"Meyer","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.omtn.2026.102917_bib67","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41467-020-14344-7","article-title":"Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis","volume":"11","author":"Dinh","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102917_bib68","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0897190019841731","article-title":"Diffuse alveolar hemorrhage following pirfenidone initiation","volume":"33","author":"Dull","year":"2020","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.omtn.2026.102917_bib69","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/resp.13024","article-title":"Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions","volume":"22","author":"Galli","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.omtn.2026.102917_bib70","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: A randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.102917_bib71","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024668","article-title":"Characteristics associated with growth differentiation factor 15 in heart failure with preserved ejection fraction and the impact of pirfenidone","volume":"11","author":"Lewis","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.omtn.2026.102917_bib72","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10741-021-10175-w","article-title":"Pirfenidone as a novel cardiac protective treatment","volume":"27","author":"Aimo","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.omtn.2026.102917_bib73","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.cardfail.2023.02.010","article-title":"Treatment adherence in a randomized controlled trial of pirfenidone in HFpEF: Determinants and impact on efficacy","volume":"29","author":"Soltani","year":"2023","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.omtn.2026.102917_bib74","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102917_bib75","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","article-title":"Breakthroughs in therapies for NASH and remaining challenges","volume":"76","author":"Ratziu","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2026.102917_bib76","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2019.04.019","article-title":"Report on the AASLD\/EASL joint workshop on clinical trial endpoints in NAFLD","volume":"71","author":"Rinella","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2026.102917_bib77","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000486398","article-title":"Bardoxolone methyl improves kidney function in patients with chronic kidney disease stage 4 and type 2 diabetes: Post-hoc analyses from bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes study","volume":"47","author":"Chin","year":"2018","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.omtn.2026.102917_bib78","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1038\/s41467-024-51056-8","article-title":"Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy","volume":"15","author":"Bai","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102917_bib79","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.102917_bib80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102917_bib81","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1038\/s41467-024-51571-8","article-title":"RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment","volume":"15","author":"Shan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102917_bib82","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.stem.2023.10.008","article-title":"VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis","volume":"30","author":"Rizvi","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2026.102917_bib83","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102917_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2025.100083","article-title":"Nanoparticles for drug delivery: Insight into in vitro and in vivo drug release from nanomedicines","volume":"4","author":"Ewii","year":"2025","journal-title":"Nano TransMed"},{"key":"10.1016\/j.omtn.2026.102917_bib85","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12967-019-1804-8","article-title":"How mRNA therapeutics are entering the monoclonal antibody field","volume":"17","author":"Van Hoecke","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.omtn.2026.102917_bib86","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.3390\/ijms21186582","article-title":"mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection","volume":"21","author":"Xu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib87","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.7150\/thno.111503","article-title":"Harnessing mRNA for heart health: A new era in cardiovascular treatment","volume":"15","author":"Peng","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.omtn.2026.102917_bib88","article-title":"Capped or uncapped? Techniques to assess the quality of mRNA molecules","volume":"37","author":"Tu","year":"2024","journal-title":"Curr. Opin. Syst. Biol."},{"key":"10.1016\/j.omtn.2026.102917_bib89","first-page":"1486","article-title":"Synthesis and properties of mRNAs containing the novel \u201canti-reverse\u201d cap analogs 7-methyl(3\u2032-O-methyl)GpppG and 7-methyl(3\u2032-deoxy)GpppG","volume":"7","author":"Stepinski","year":"2001","journal-title":"RNA"},{"key":"10.1016\/j.omtn.2026.102917_bib90","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1002\/cpz1.39","article-title":"Cap 1 messenger RNA synthesis with co-transcriptional CleanCap\u00ae analog by in vitro transcription","volume":"1","author":"Henderson","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.omtn.2026.102917_bib91","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1261\/rna.701307","article-title":"Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells","volume":"13","author":"Grudzien-Nogalska","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.omtn.2026.102917_bib92","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.apsb.2023.11.003","article-title":"A novel deep generative model for mRNA vaccine development: Designing 50 UTRs with N1-methyl-pseudouridine modification","volume":"14","author":"Tang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.omtn.2026.102917_bib93","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.102917_bib94","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0968-0004(00)89102-1","article-title":"AU-rich elements: Characterization and importance in mRNA degradation","volume":"20","author":"Chen","year":"1995","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib95","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.omtn.2022.10.003","article-title":"Cytidine-containing tails robustly enhance and prolong protein production of synthetic mRNA in cell and in vivo","volume":"30","author":"Li","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102917_bib96","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41587-024-02174-7","article-title":"Branched chemically modified poly(a) tails enhance the translation capacity of mRNA","volume":"43","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102917_bib97","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41580-021-00417-y","article-title":"Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression","volume":"23","author":"Passmore","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2026.102917_bib98","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/ten.tea.2017.0485","article-title":"Maximizing the translational yield of mRNA therapeutics by minimizing 5\u2019-UTRs","volume":"25","author":"Trepotec","year":"2019","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.omtn.2026.102917_bib99","doi-asserted-by":"crossref","first-page":"10075","DOI":"10.1093\/nar\/gkad687","article-title":"Precise genome editing of the kozak sequence enables bidirectional and quantitative modulation of protein translation to anticipated levels without affecting transcription","volume":"51","author":"Xie","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102917_bib100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/vaccines8010123","article-title":"mRNA vaccines encoding the HA protein of influenza a H1N1 virus delivered by cationic lipid nanoparticles induce protective immune responses in mice","volume":"8","author":"Zhuang","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtn.2026.102917_bib101","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s43586-023-00246-7","article-title":"Nanotechnology-based mRNA vaccines","volume":"3","author":"Chen","year":"2023","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.omtn.2026.102917_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29183","article-title":"Viral codon optimization on SARS-CoV-2 spike boosts immunity in the development of COVID-19 mRNA vaccines","volume":"95","author":"Lai","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.omtn.2026.102917_bib134","article-title":"Legumain in situ engineering promotes efferocytosis of CAR macrophage to treat cardiac fibrosis","volume":"37","author":"Liu","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2026.102917_bib135","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304378","article-title":"In vivo mRNA CAR T cell engineering via targeted ionizable lipid nanoparticles with extrahepatic tropism","volume":"20","author":"Billingsley","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.omtn.2026.102917_bib103","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.3390\/pharmaceutics14122675","article-title":"Lipid-Polymer Hybrid Nanoparticles for mRNA Delivery to Dendritic Cells: Impact of Lipid Composition on Performance in Different Media","volume":"14","author":"Kliesch","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2026.102917_bib104","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7150\/thno.84291","article-title":"Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape","volume":"14","author":"Li","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.omtn.2026.102917_bib105","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","article-title":"Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment","volume":"9","author":"Kojima","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102917_bib106","article-title":"Rapid Surface Display of mRNA Antigens by Bacteria-Derived Outer Membrane Vesicles for a Personalized Tumor Vaccine","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2026.102917_bib107","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.omtn.2026.102917_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107847","article-title":"Messenger RNA (mRNA) based therapeutics in transforming cardiovascular care: Progress, regulatory challenges and future perspectives","volume":"218","author":"Khan","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.omtn.2026.102917_bib109","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41467-022-35637-z","article-title":"Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis","volume":"14","author":"Han","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102917_bib110","article-title":"Dendrimers improve apolipoprotein nanoparticle mRNA delivery to immune cells","volume":"38","author":"Trines","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2026.102917_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2025.100082","article-title":"Liposome-encapsulated therapies: Precision medicine for inflammatory lung disorders","volume":"4","author":"Shaikh","year":"2025","journal-title":"Nano TransMed"},{"key":"10.1016\/j.omtn.2026.102917_bib112","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.smim.2017.08.015","article-title":"Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics\u2014an innate immune system standpoint","volume":"34","author":"Granot","year":"2017","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.omtn.2026.102917_bib113","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2026.102917_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2021.715844","article-title":"Anaphylaxis to pfizer\/BioNTech mRNA COVID-19 vaccine in a patient with clinically confirmed PEG allergy","volume":"2","author":"McSweeney","year":"2021","journal-title":"Front. Allergy"},{"key":"10.1016\/j.omtn.2026.102917_bib115","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1039\/D5NH00230C","article-title":"Influence of hydrophilic polymers on the accelerated blood clearance of mRNA lipid nanoparticles upon repeated administration","volume":"10","author":"Hassanel","year":"2025","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.omtn.2026.102917_bib116","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1039\/D4PY00206G","article-title":"Rational design of polymer-based mRNA delivery systems for cancer treatment","volume":"15","author":"Wan","year":"2024","journal-title":"Polym. Chem."},{"key":"10.1016\/j.omtn.2026.102917_bib117","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.1002\/adma.201602319","article-title":"PGMA-based star-like polycations with plentiful hydroxyl groups act as highly efficient miRNA delivery nanovectors for effective applications in heart diseases","volume":"28","author":"Li","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2026.102917_bib118","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304966120","article-title":"Inhaled mRNA nanoparticles dual-targeting cancer cells and macrophages in the lung for effective transfection","volume":"120","author":"Tang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102917_bib119","article-title":"The pivotal role of chemical modifications in mRNA therapeutics","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omtn.2026.102917_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122747","article-title":"Recent progress in engineered extracellular vesicles and their biomedical applications","volume":"350","author":"Mazahir","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib121","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jconrel.2023.11.057","article-title":"Extracellular vesicles and their engineering strategies, delivery systems, and biomedical applications","volume":"365","author":"Yang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102917_bib122","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bmt.2023.01.003","article-title":"Exosomes-based particles as inhalable COVID-19 vaccines","volume":"4","author":"Fan","year":"2023","journal-title":"Biomed. Technol."},{"key":"10.1016\/j.omtn.2026.102917_bib123","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1158\/1535-7163.MCT-17-0827","article-title":"Anti-HER2 scFv-directed extracellular vesicle-mediated mRNA-based gene delivery inhibits growth of HER2-positive human breast tumor xenografts by prodrug activation","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omtn.2026.102917_bib124","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12951-024-02634-x","article-title":"Exosome for mRNA delivery: Strategies and therapeutic applications","volume":"22","author":"Iqbal","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.omtn.2026.102917_bib125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nnano.2012.73","article-title":"Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery","volume":"7","author":"Lee","year":"2012","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2026.102917_bib126","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41563-021-01020-4","article-title":"Programmable icosahedral shell system for virus trapping","volume":"20","author":"Sigl","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.omtn.2026.102917_bib127","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nature04586","article-title":"Folding DNA to create nanoscale shapes and patterns","volume":"440","author":"Rothemund","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102917_bib128","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nmat1741","article-title":"Enzyme-catalysed assembly of DNA hydrogel","volume":"5","author":"Um","year":"2006","journal-title":"Nat. Mater."},{"key":"10.1016\/j.omtn.2026.102917_bib129","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1021\/ja209351u","article-title":"Spherical nucleic acids","volume":"134","author":"Cutler","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.omtn.2026.102917_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202101224","article-title":"mRNA delivery by a pH-responsive DNA nano-hydrogel","volume":"17","author":"Fu","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.omtn.2026.102917_bib131","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41467-023-36156-1","article-title":"3D RNA-scaffolded wireframe origami","volume":"14","author":"Parsons","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102917_bib132","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202417642","article-title":"Folding of mRNA-DNA origami for controlled translation and viral vector packaging","volume":"37","author":"Seitz","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2026.102917_bib133","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1039\/D2RA06888E","article-title":"Effects of morphology and size of nanoscale drug carriers on cellular uptake and internalization process: A review","volume":"13","author":"Zhang","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.omtn.2026.102917_bib136","article-title":"Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver","volume":"7","author":"Kim","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.102917_bib137","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1016\/j.ymthe.2024.10.020","article-title":"Efficient and selective kidney targeting by chemically modified carbohydrate conjugates","volume":"32","author":"Kumar","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102917_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115042","article-title":"Engineering nanoparticle toolkits for mRNA delivery","volume":"200","author":"Sun","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2026.102917_bib139","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2026.102917_bib140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/13506129.2019.1681392","article-title":"APOE polymorphism in ATTR amyloidosis patients treated with lipid nanoparticle siRNA","volume":"27","author":"Niemietz","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.omtn.2026.102917_bib141","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtn.2026.102917_bib142","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41563-025-02320-9","article-title":"Tissue-specific mRNA delivery and prime editing with peptide\u2013ionizable lipid nanoparticles","volume":"25","author":"Lin","year":"2026","journal-title":"Nat. Mater."},{"key":"10.1016\/j.omtn.2026.102917_bib143","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65344-4","article-title":"Transient overexpression of hPKM2 in porcine cardiomyocytes prevents heart failure after myocardial infarction","volume":"16","author":"Sun","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102917_bib144","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.omtm.2018.04.003","article-title":"Biocompatible, purified VEGF-a mRNA improves cardiac function after intracardiac injection 1 week post-myocardial infarction in swine","volume":"9","author":"Carlsson","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.102917_bib145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-025-02191-1","article-title":"Intranasal prime-boost RNA vaccination elicits potent T cell response for lung cancer therapy","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduction Targeted Ther."},{"key":"10.1016\/j.omtn.2026.102917_bib146","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study","volume":"22","author":"Rowe","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.omtn.2026.102917_bib147","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/acs.nanolett.0c05039","article-title":"In situ transforming RNA nanovaccines from polyethylenimine functionalized graphene oxide hydrogel for durable cancer immunotherapy","volume":"21","author":"Yin","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.omtn.2026.102917_bib202","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/s41467-025-59093-7","article-title":"Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile","volume":"16","author":"Yan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102917_bib203","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202501401","article-title":"Advances in mRNA-lipid nanoparticle engineering for immune cell targeting and immune modulation","volume":"9","author":"Kim","year":"2025","journal-title":"Small Methods"},{"key":"10.1016\/j.omtn.2026.102917_bib175","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jhep.2021.08.011","article-title":"Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model","volume":"75","author":"Yang","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2026.102917_bib170","article-title":"Cellular delivery of relaxin-2 mRNA as a potential treatment for kidney fibrosis","volume":"21","author":"Ding","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.omtn.2026.102917_bib148","doi-asserted-by":"crossref","first-page":"C1015","DOI":"10.1152\/ajpcell.00541.2024","article-title":"Role of TGF-\u03b2\/SMAD\/YAP\/TAZ signaling in skeletal muscle fibrosis","volume":"328","author":"Gallardo","year":"2025","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.omtn.2026.102917_bib149","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3892\/ijmm.2021.4965","article-title":"TGF-\u03b21: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (review)","volume":"48","author":"Ye","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.omtn.2026.102917_bib150","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.3390\/ijms22116107","article-title":"Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-\u03b2 and the Ubiquitin-Proteasome Pathway","volume":"22","author":"Inui","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib151","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","article-title":"Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.omtn.2026.102917_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109568","article-title":"Nuclear factor-kappa B and its role in inflammatory lung disease","volume":"345","author":"Alharbi","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.omtn.2026.102917_bib153","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02307-2021","article-title":"Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts","volume":"60","author":"Guan","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.omtn.2026.102917_bib154","article-title":"The pivotal role of TGF-\u03b2\/smad pathway in fibrosis pathogenesis and treatment","volume":"15","author":"Chen","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omtn.2026.102917_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1450038","article-title":"Notch signaling regulates pulmonary fibrosis","volume":"12","author":"Zhang","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omtn.2026.102917_bib156","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1164\/rccm.202402-0290VP","article-title":"A long and winding road: Drug development in idiopathic pulmonary fibrosis","volume":"209","author":"Spagnolo","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtn.2026.102917_bib157","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/14712598.2020.1735346","article-title":"Antibody-based therapies for idiopathic pulmonary fibrosis","volume":"20","author":"Sgalla","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2026.102917_bib158","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40820-025-01665-9","article-title":"Developing mRNA nanomedicines with advanced targeting functions","volume":"17","author":"Wang","year":"2025","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.omtn.2026.102917_bib159","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41419-020-03178-2","article-title":"Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-\u03baB\/NLRP3-mediated epithelial\u2013mesenchymal transition and inflammation","volume":"11","author":"Peng","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtn.2026.102917_bib160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jb\/mvp148","article-title":"Bone morphogenetic protein receptors and signal transduction","volume":"147","author":"Miyazono","year":"2010","journal-title":"J. Biochem."},{"key":"10.1016\/j.omtn.2026.102917_bib161","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1038\/s41467-025-61688-z","article-title":"Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury","volume":"16","author":"Zhao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102917_bib162","doi-asserted-by":"crossref","first-page":"9095","DOI":"10.1007\/s12274-024-6747-6","article-title":"LPA1 antagonist-derived LNPs deliver A20 mRNA and promote anti-fibrotic activities","volume":"17","author":"Yan","year":"2024","journal-title":"Nano Res."},{"key":"10.1016\/j.omtn.2026.102917_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117178","article-title":"Emerging role of BMPs\/BMPR2 signaling pathway in treatment for pulmonary fibrosis","volume":"178","author":"Ye","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtn.2026.102917_bib164","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3390\/cells8101130","article-title":"The interactivity between TGF\u03b2 and BMP signaling in organogenesis, fibrosis, and cancer","volume":"8","author":"Dituri","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2026.102917_bib165","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301190","article-title":"PUM1 promotes tumor progression by activating DEPTOR-meditated glycolysis in gastric cancer","volume":"10","author":"Yin","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib166","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.actbio.2025.01.040","article-title":"Lung-targeted delivery of PTEN mRNA combined with anti-PD-1-mediated immunotherapy for in situ lung cancer treatment","volume":"194","author":"Hu","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.omtn.2026.102917_bib177","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbaf057","article-title":"Fibrotic lung ECM upregulates SDC4\/integrin-\u03b1v\u03b21 interaction and the interfering peptide SDC487-131 and its derivative peptides alleviate pulmonary fibrosis","volume":"12","author":"Zhu","year":"2025","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.omtn.2026.102917_bib167","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.3390\/ijms25116262","article-title":"Modified mRNA-Mediated CCN5 Gene Transfer Ameliorates Cardiac Dysfunction and Fibrosis without Adverse Structural Remodeling","volume":"25","author":"Song","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib168","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.7150\/thno.52843","article-title":"CircUbe3a from M2 macrophage-derived small extracellular vesicles mediates myocardial fibrosis after acute myocardial infarction","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.omtn.2026.102917_bib169","article-title":"Tissue-engineered cardiac patches enriched with IGF1 modified mRNA alleviate myocardial infarction by enhancing cell survival and angiogenesis","volume":"36","author":"Yan","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.omtn.2026.102917_bib171","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s42004-025-01491-5","article-title":"Towards precision medicine using biochemically triggered cleavable conjugation","volume":"8","author":"Parshad","year":"2025","journal-title":"Commun. Chem."},{"key":"10.1016\/j.omtn.2026.102917_bib172","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.3390\/molecules25235649","article-title":"pH-sensitive biomaterials for drug delivery","volume":"25","author":"Zhuo","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2026.102917_bib173","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1038\/s41467-025-63415-0","article-title":"Modulating tumor collagen fiber alignment for enhanced lung cancer immunotherapy via inhaled RNA","volume":"16","author":"Hu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102917_bib174","article-title":"Inhaled mRNA nanoformulation with biogenic ribosomal protein reverses established pulmonary fibrosis in a bleomycin-induced murine model","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2026.102917_bib176","doi-asserted-by":"crossref","first-page":"34375","DOI":"10.1021\/acsnano.4c13404","article-title":"Prevent and reverse metabolic dysfunction-associated steatohepatitis and hepatic fibrosis via mRNA-mediated liver-specific antibody therapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtn.2026.102917_bib178","series-title":"Hepatic Stellate Cells: Methods and Protocols","first-page":"269","article-title":"Hepatic stellate cell targeting using peptide-modified biologicals","author":"Bansal","year":"2023"},{"key":"10.1016\/j.omtn.2026.102917_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114378","article-title":"Nintedanib-amplified effects of HSP47 siRNA on liver fibrosis therapy by inhibiting collagen secretion","volume":"388","author":"Yang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102917_bib181","article-title":"Freezing shock monocytes deliver antisense oligonucleotides via liposomes for the treatment of idiopathic pulmonary fibrosis","volume":"21","author":"Li","year":"2026","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.omtn.2026.102917_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114424","article-title":"Genome editing of Spp1 by inhalable CRISPR\/Cas9 formulation for treating pulmonary fibrosis","volume":"389","author":"Bao","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102917_bib183","doi-asserted-by":"crossref","first-page":"24842","DOI":"10.1021\/acsnano.4c05088","article-title":"Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 Axis","volume":"18","author":"Korzun","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtn.2026.102917_bib184","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1194\/jlr.D029546","article-title":"Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways","volume":"53","author":"Huang","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.omtn.2026.102917_bib185","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/vaccines13010014","article-title":"Regulating Immune Responses Induced by PEGylated Messenger RNA-Lipid Nanoparticle Vaccine","volume":"13","author":"Jo","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtn.2026.102917_bib186","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102917_bib187","doi-asserted-by":"crossref","first-page":"22989","DOI":"10.1021\/acsnano.4c04519","article-title":"Time-Resolved Inspection of Ionizable Lipid-Facilitated Lipid Nanoparticle Disintegration and Cargo Release at an Early Endosomal Membrane Mimic","volume":"18","author":"Aliakbarinodehi","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtn.2026.102917_bib188","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jconrel.2024.10.044","article-title":"Hepatic stellate cell-targeted chemo-gene therapy for liver fibrosis using fluorinated peptide-lipid hybrid nanoparticles","volume":"376","author":"Lai","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102917_bib189","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202515130","article-title":"Fusion peptide-incorporated lipid nanoparticles boost endosomal escape and enhance cytosolic mRNA delivery","volume":"38","author":"Meng","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2026.102917_bib190","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/pharmaceutics17070803","article-title":"Endo\/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy","volume":"17","author":"Wang","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2026.102917_bib191","doi-asserted-by":"crossref","first-page":"46044","DOI":"10.1021\/acsami.4c08896","article-title":"Size-Controllable and Monodispersed Lipid Nanoparticle Production with High mRNA Delivery Efficiency Using 3D-Printed Ring Micromixers","volume":"16","author":"Hong","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.omtn.2026.102917_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100161","article-title":"Lab-scale siRNA and mRNA LNP manufacturing by various microfluidic mixing techniques \u2013 an evaluation of particle properties and efficiency","volume":"12","author":"J\u00fcrgens","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.omtn.2026.102917_bib193","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202312038","article-title":"Oxidized mRNA Lipid Nanoparticles for In Situ Chimeric Antigen Receptor Monocyte Engineering","volume":"34","author":"Mukalel","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.omtn.2026.102917_bib194","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbaf023","article-title":"Development of lyophilized mRNA-LNPs with high stability and transfection efficiency in specific cells and tissues","volume":"12","author":"Wang","year":"2025","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.omtn.2026.102917_bib195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.53941\/rmd.2024.100003","article-title":"Application of Saccharide Cryoprotectants in the Freezing or Lyophilization Process of Lipid Nanoparticles Encapsulating Gene Drugs for Regenerative Medicine","volume":"1","author":"Li","year":"2024","journal-title":"RMD"},{"key":"10.1016\/j.omtn.2026.102917_bib196","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/17425247.2023.2162876","article-title":"Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out","volume":"20","author":"De","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.omtn.2026.102917_bib197","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s42003-024-06235-0","article-title":"Overcoming thermostability challenges in mRNA\u2013lipid nanoparticle systems with piperidine-based ionizable lipids","volume":"7","author":"Hashiba","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omtn.2026.102917_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114709","article-title":"Lipid nanoparticles containing zwitterionic lipids versatilely enhance the efficiency of mRNA delivery","volume":"392","author":"Suzuki","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102917_bib201","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.1021\/acsami.5c21156","article-title":"Magnetic Lipid Nanoparticles for Targeted mRNA Delivery and Enhanced Organ-Specific Expression","volume":"18","author":"Jin","year":"2026","journal-title":"ACS Appl. Mater. Interfaces"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:30:45Z","timestamp":1794432645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126000880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":202,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2162253126000880"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102917","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking the potential of mRNA nanomedicines for comprehensive fibrosis therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102917","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102917"}}